﻿<?xml version="1.0" encoding="UTF-8"?>
<records>
  <record>
    <language>eng</language>
    <publisher>Science and Education Publishing</publisher>
    <journalTitle>American Journal of Medical Case Reports</journalTitle>
    <eissn>2374-216X</eissn>
    <publicationDate>2021-10-09</publicationDate>
    <volume>9</volume>
    <issue>12</issue>
    <startPage>725</startPage>
    <endPage>729</endPage>
    <doi>10.12691/ajmcr-9-12-17</doi>
    <publisherRecordId>AJMCR202191217</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Dapagliflozin Induced Acute Tubulo-Interstitial Nephritis: A Case Report and Literature Review</title>
    <authors>
      <author>
        <name>Nida Saleem</name>
        <email>nidasaa1968@gmail.com</email>
        <affiliationId>1</affiliationId>
      </author>
      <author>
        <name>Saima Bashir</name>
        <affiliationId>1</affiliationId>
      </author>
      <author>
        <name>Syed Nayer Mahmud</name>
        <affiliationId>1</affiliationId>
      </author>
      <author>
        <name>Muhammad Haneef</name>
        <affiliationId>1</affiliationId>
      </author>
    </authors>
    <affiliationsList>
      <affiliationName affiliationId="1">Nephrology Department, Shifa International Hospital, Islamabad, 00000, Pakistan</affiliationName>
    </affiliationsList>
    <abstract language="eng">We report a case of an elderly male patient, who presented with acute kidney injury on background of diabetic nephropathy, secondary to dapagliflozin induced acute tubulo-interstitial nephritis requiring hemodialysis sessions. Histopathological findings are consistent with moderate tubulo-interstitial inflammation with mixed lymphocytic and eosinophilic inflammatory deposits. The patient responded well to cessation of causative medication and upon initiation of high dose steroids. The direct cause and effect relationship between dapagliflozin initiation and development of acute tubulo-interstitial nephritis is indicative of dapagliflozin being responsible for marked renal deterioration, as seen in this patient.</abstract>
    <fullTextUrl format="pdf">http://pubs.sciepub.com/ajmcr/9/12/17/ajmcr-9-12-17.pdf</fullTextUrl>
    <keywords language="eng">
      <keyword>Acute interstitial nephritis (AIN)</keyword>
      <keyword>Diabetes</keyword>
      <keyword>dapagliflozin</keyword>
      <keyword>SGLT2 inhibitors</keyword>
      <keyword>acute kidney injury (AKI)</keyword>
    </keywords>
  </record>
</records>